166 related articles for article (PubMed ID: 37093598)
1. Longitudinal Analysis of Cancer Risk in Children and Adults With Germline PTEN Variants.
Yehia L; Plitt G; Tushar AM; Joo J; Burke CA; Campbell SC; Heiden K; Jin J; Macaron C; Michener CM; Pederson HJ; Radhakrishnan K; Shin J; Tamburro J; Patil S; Eng C
JAMA Netw Open; 2023 Apr; 6(4):e239705. PubMed ID: 37093598
[TBL] [Abstract][Full Text] [Related]
2. Copy Number Variation and Clinical Outcomes in Patients With Germline PTEN Mutations.
Yehia L; Seyfi M; Niestroj LM; Padmanabhan R; Ni Y; Frazier TW; Lal D; Eng C
JAMA Netw Open; 2020 Jan; 3(1):e1920415. PubMed ID: 32003824
[TBL] [Abstract][Full Text] [Related]
3. Second malignant neoplasms in patients with Cowden syndrome with underlying germline PTEN mutations.
Ngeow J; Stanuch K; Mester JL; Barnholtz-Sloan JS; Eng C
J Clin Oncol; 2014 Jun; 32(17):1818-24. PubMed ID: 24778394
[TBL] [Abstract][Full Text] [Related]
4. High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome.
Bubien V; Bonnet F; Brouste V; Hoppe S; Barouk-Simonet E; David A; Edery P; Bottani A; Layet V; Caron O; Gilbert-Dussardier B; Delnatte C; Dugast C; Fricker JP; Bonneau D; Sevenet N; Longy M; Caux F;
J Med Genet; 2013 Apr; 50(4):255-63. PubMed ID: 23335809
[TBL] [Abstract][Full Text] [Related]
5. Lifetime cancer risks in individuals with germline PTEN mutations.
Tan MH; Mester JL; Ngeow J; Rybicki LA; Orloff MS; Eng C
Clin Cancer Res; 2012 Jan; 18(2):400-7. PubMed ID: 22252256
[TBL] [Abstract][Full Text] [Related]
6. Cancer risks by sex and variant type in PTEN hamartoma tumor syndrome.
Hendricks LAJ; Hoogerbrugge N; Mensenkamp AR; Brunet J; Lleuger-Pujol R; Høberg-Vetti H; Tveit Haavind M; Innella G; Turchetti D; Aretz S; Spier I; Tischkowitz M; Jahn A; Links TP; Olderode-Berends MJW; Blatnik A; Leter EM; Evans DG; Woodward ER; Steinke-Lange V; Anastasiadou VC; Colas C; Villy MC; Benusiglio PR; Gerasimenko A; Barili V; Branchaud M; Houdayer C; Tesi B; Yazicioglu MO; van der Post RS; Schuurs-Hoeijmakers JHM; ; Vos JR
J Natl Cancer Inst; 2023 Jan; 115(1):93-103. PubMed ID: 36171661
[TBL] [Abstract][Full Text] [Related]
7. Natural History of Thyroid Disease in Children with PTEN Hamartoma Tumor Syndrome.
Smith JR; Liu E; Church AJ; Asch E; Cherella CE; Srivastava S; Kamihara J; Wassner AJ
J Clin Endocrinol Metab; 2021 Mar; 106(3):e1121-e1130. PubMed ID: 33347563
[TBL] [Abstract][Full Text] [Related]
8. Papillary renal cell carcinoma is associated with PTEN hamartoma tumor syndrome.
Mester JL; Zhou M; Prescott N; Eng C
Urology; 2012 May; 79(5):1187.e1-7. PubMed ID: 22381246
[TBL] [Abstract][Full Text] [Related]
9. PTEN hamartoma tumour syndrome: case report based on data from the Iranian hereditary colorectal cancer registry and literature review.
Rahmatinejad Z; Goshayeshi L; Bergquist R; Goshayeshi L; Golabpour A; Hoseini B
Diagn Pathol; 2023 Apr; 18(1):43. PubMed ID: 37016356
[TBL] [Abstract][Full Text] [Related]
10. Unexpected cancer-predisposition gene variants in Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome patients without underlying germline PTEN mutations.
Yehia L; Ni Y; Sesock K; Niazi F; Fletcher B; Chen HJL; LaFramboise T; Eng C
PLoS Genet; 2018 Apr; 14(4):e1007352. PubMed ID: 29684080
[TBL] [Abstract][Full Text] [Related]
11. Clinical Implications for Germline PTEN Spectrum Disorders.
Ngeow J; Sesock K; Eng C
Endocrinol Metab Clin North Am; 2017 Jun; 46(2):503-517. PubMed ID: 28476234
[TBL] [Abstract][Full Text] [Related]
12. Exploring the neurological features of individuals with germline PTEN variants: A multicenter study.
Dhawan A; Baitamouni S; Liu D; Busch R; Klaas P; Frazier TW; Srivastava S; Parikh S; Hsich GE; Friedman NR; Ritter DM; Hardan AY; Martinez-Agosto JA; Sahin M; Eng C
Ann Clin Transl Neurol; 2024 May; 11(5):1301-1309. PubMed ID: 38501559
[TBL] [Abstract][Full Text] [Related]
13. Thyroid nodules and cancer in children with PTEN hamartoma tumor syndrome.
Smith JR; Marqusee E; Webb S; Nose V; Fishman SJ; Shamberger RC; Frates MC; Huang SA
J Clin Endocrinol Metab; 2011 Jan; 96(1):34-7. PubMed ID: 20962022
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer risk and clinical implications for germline PTEN mutation carriers.
Ngeow J; Sesock K; Eng C
Breast Cancer Res Treat; 2017 Aug; 165(1):1-8. PubMed ID: 26700035
[TBL] [Abstract][Full Text] [Related]
15. Incidence and clinical characteristics of thyroid cancer in prospective series of individuals with Cowden and Cowden-like syndrome characterized by germline PTEN, SDH, or KLLN alterations.
Ngeow J; Mester J; Rybicki LA; Ni Y; Milas M; Eng C
J Clin Endocrinol Metab; 2011 Dec; 96(12):E2063-71. PubMed ID: 21956414
[TBL] [Abstract][Full Text] [Related]
16. Development and Progression of Thyroid Disease in
Plitt G; Brewer T; Yehia L; Jin J; Shin J; Eng C
Thyroid; 2022 Sep; 32(9):1094-1100. PubMed ID: 35761794
[No Abstract] [Full Text] [Related]
17. Genotype-phenotype associations in a large PTEN Hamartoma Tumor Syndrome (PHTS) patient cohort.
Hendricks LAJ; Hoogerbrugge N; Venselaar H; Aretz S; Spier I; Legius E; Brems H; de Putter R; Claes KBM; Evans DG; Woodward ER; Genuardi M; Brugnoletti F; van Ierland Y; Dijke K; Tham E; Tesi B; Schuurs-Hoeijmakers JHM; Branchaud M; Salvador H; Jahn A; Schnaiter S; Anastasiadou VC; Brunet J; Oliveira C; Roht L; Blatnik A; Irmejs A; ; Mensenkamp AR; Vos JR
Eur J Med Genet; 2022 Dec; 65(12):104632. PubMed ID: 36270489
[TBL] [Abstract][Full Text] [Related]
18. A review on age-related cancer risks in PTEN hamartoma tumor syndrome.
Hendricks LAJ; Hoogerbrugge N; Schuurs-Hoeijmakers JHM; Vos JR
Clin Genet; 2021 Feb; 99(2):219-225. PubMed ID: 33140411
[TBL] [Abstract][Full Text] [Related]
19. Cell-free DNA fragmentomics and second malignant neoplasm risk in patients with PTEN hamartoma tumor syndrome.
Liu D; Yehia L; Dhawan A; Ni Y; Eng C
Cell Rep Med; 2024 Feb; 5(2):101384. PubMed ID: 38242121
[TBL] [Abstract][Full Text] [Related]
20. Head circumference in the clinical detection of PTEN hamartoma tumor syndrome in a clinic population at high-risk of breast cancer.
Shiovitz S; Everett J; Huang SC; Orloff MS; Eng C; Gruber SB
Breast Cancer Res Treat; 2010 Nov; 124(2):459-65. PubMed ID: 20349131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
